These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 21566509)
21. Pharmacokinetics of voriconazole after oral and intravenous administration to horses. Davis JL; Salmon JH; Papich MG Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses. Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020 [TBL] [Abstract][Full Text] [Related]
23. Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis. Weiler S; Zoller H; Graziadei I; Vogel W; Bellmann-Weiler R; Joannidis M; Bellmann R Antimicrob Agents Chemother; 2007 Sep; 51(9):3459-60. PubMed ID: 17606679 [No Abstract] [Full Text] [Related]
24. Plasma concentrations of voriconazole in falcons. Schmidt V; Demiraj F; Di Somma A; Bailey T; Ungemach FR; Krautwald-Junghanns ME Vet Rec; 2007 Aug; 161(8):265-8. PubMed ID: 17720963 [TBL] [Abstract][Full Text] [Related]
25. Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections. Boyd NK; Zoellner CL; Swancutt MA; Bhavan KP Antimicrob Agents Chemother; 2012 Nov; 56(11):6001-2. PubMed ID: 22890768 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses. Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636 [TBL] [Abstract][Full Text] [Related]
27. Single and multidose ocular kinetics and stability analysis of extemporaneous formulation of topical voriconazole in humans. Senthilkumari S; Lalitha P; Prajna NV; Haripriya A; Nirmal J; Gupta P; Velpandian T Curr Eye Res; 2010 Nov; 35(11):953-60. PubMed ID: 20958183 [TBL] [Abstract][Full Text] [Related]
28. Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients. Heng SC; Snell GI; Levvey B; Keating D; Westall GP; Williams TJ; Whitford H; Nation RL; Slavin MA; Morrissey O; Kong DC Antimicrob Agents Chemother; 2013 Sep; 57(9):4581-3. PubMed ID: 23817382 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients. Peng LW; Lien YH Am J Kidney Dis; 2005 Jan; 45(1):162-6. PubMed ID: 15696456 [TBL] [Abstract][Full Text] [Related]
30. Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation. Ruiz S; Papy E; Da Silva D; Nataf P; Massias L; Wolff M; Bouadma L Intensive Care Med; 2009 Jan; 35(1):183-4. PubMed ID: 18795256 [No Abstract] [Full Text] [Related]
32. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets. Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785 [TBL] [Abstract][Full Text] [Related]
33. Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy. Henry ME; Bolo NR; Zuo CS; Villafuerte RA; Cayetano K; Glue P; Damle BD; Andrews E; Lauriat TL; Rana NS; Churchill JH; Renshaw PF Antimicrob Agents Chemother; 2013 Nov; 57(11):5271-6. PubMed ID: 23939898 [TBL] [Abstract][Full Text] [Related]
34. Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients. Han K; Capitano B; Bies R; Potoski BA; Husain S; Gilbert S; Paterson DL; McCurry K; Venkataramanan R Antimicrob Agents Chemother; 2010 Oct; 54(10):4424-31. PubMed ID: 20679503 [TBL] [Abstract][Full Text] [Related]
35. Effect of grapefruit juice on serum voriconazole concentrations in the mouse. Sugar AM; Liu XP Med Mycol; 2000 Jun; 38(3):209-12. PubMed ID: 10892988 [TBL] [Abstract][Full Text] [Related]
37. Adverse reactions to voriconazole. Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics in the development of antifungal compounds. Andes D Curr Opin Investig Drugs; 2003 Aug; 4(8):991-8. PubMed ID: 14508883 [TBL] [Abstract][Full Text] [Related]
39. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults. Keirns J; Sawamoto T; Holum M; Buell D; Wisemandle W; Alak A Antimicrob Agents Chemother; 2007 Feb; 51(2):787-90. PubMed ID: 17116670 [TBL] [Abstract][Full Text] [Related]
40. Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications. Geist MJ; Egerer G; Burhenne J; Riedel KD; Mikus G Antimicrob Agents Chemother; 2007 Sep; 51(9):3455-6. PubMed ID: 17606672 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]